Astute Medical
bioMérieux is a global leader in the field of in vitro diagnostics, dedicated to improving health worldwide through the development, production, and marketing of diagnostic solutions. Since 1963, the company has been committed to public health, innovation, and sustainability, offering high-quality products and services to identify disease causes and contamination sources, and to protect and improve patient and consumer health. The company emphasizes data confidentiality, data processing compliance with GDPR, and collaborates with cloud service providers like AWS to ensure data security and privacy. It also offers a range of diagnostic products, including molecular diagnostics, blood culture testing systems, syndromic infectious disease testing, and immunoassay diagnostics equipment.
Industries
Nr. of Employees
medium (51-250)
Astute Medical
Harry-Glück-Platz 2/5.OG, A-1100 Wien
Patents
Follistatin-related protein 3 for diagnosis and prognosis of renal injury and renal failure
US-11506672-B2
View DetailsBlood biomarkers for appendicitis and diagnostics methods using biomarkers
US-11371096-B2
View DetailsMethods and compositions for diagnosis and prognosis of renal injury and renal failure
US-11346846-B2
View DetailsMethods and compositions for diagnosis and prognosis of renal injury and renal failure
US-11143658-B2
View Details
Follistatin-related protein 3 for diagnosis and prognosis of renal injury and renal failure
US-11506672-B2
View DetailsBlood biomarkers for appendicitis and diagnostics methods using biomarkers
US-11371096-B2
View DetailsMethods and compositions for diagnosis and prognosis of renal injury and renal failure
US-11346846-B2
View DetailsMethods and compositions for diagnosis and prognosis of renal injury and renal failure
US-11143658-B2
View DetailsProducts
Syndromic multiplex molecular panels
Multiplex molecular panels for simultaneous detection of multiple infectious disease targets to accelerate pathogen identification in syndromic presentations.
Mass spectrometry systems for microbial identification
Mass spectrometry-based systems and workflows for rapid, high-throughput species-level identification of microorganisms integrated into laboratory automation.
Automated environmental monitoring and trending platform
Digital environmental monitoring solution providing automated sampling, secure data capture, trending and compliance reporting to support manufacturing quality control and regulatory audits.
Cloud-hosted laboratory analytics and syndromic trends platform
Cloud-hosted analytics platform that aggregates device telemetry and laboratory data, provides dashboards and reporting, supports pseudonymized/anonymized exports for R&D and epidemiology and includes contractual subprocessor controls and automated updates.
Syndromic multiplex molecular panels
Multiplex molecular panels for simultaneous detection of multiple infectious disease targets to accelerate pathogen identification in syndromic presentations.
Mass spectrometry systems for microbial identification
Mass spectrometry-based systems and workflows for rapid, high-throughput species-level identification of microorganisms integrated into laboratory automation.
Automated environmental monitoring and trending platform
Digital environmental monitoring solution providing automated sampling, secure data capture, trending and compliance reporting to support manufacturing quality control and regulatory audits.
Cloud-hosted laboratory analytics and syndromic trends platform
Cloud-hosted analytics platform that aggregates device telemetry and laboratory data, provides dashboards and reporting, supports pseudonymized/anonymized exports for R&D and epidemiology and includes contractual subprocessor controls and automated updates.
Services
Cloud-hosted platform services for remote device connectivity, secure telemetry aggregation, analytics dashboards, anonymized dataset exports, contractual subprocessor management and automated system updates.
SaaS service that aggregates pseudonymized or anonymized laboratory results from distributed terminals to produce real-time pathogen surveillance reports, epidemiological dashboards and aggregated datasets for public health and research.
On-site and documentation services to validate assays and support regulatory submissions, including assay validation, qualification protocols and compliance documentation for laboratory and pharmaceutical customers.
Instructor-led courses, webinars and workshops covering clinical microbiology techniques, accreditation standards and laboratory workflow optimization.
Technical support, maintenance contracts and a digital customer portal for ordering, tracking, accessing documentation and managing service requests for laboratory products and consumables.
Cloud-hosted platform services for remote device connectivity, secure telemetry aggregation, analytics dashboards, anonymized dataset exports, contractual subprocessor management and automated system updates.
SaaS service that aggregates pseudonymized or anonymized laboratory results from distributed terminals to produce real-time pathogen surveillance reports, epidemiological dashboards and aggregated datasets for public health and research.
On-site and documentation services to validate assays and support regulatory submissions, including assay validation, qualification protocols and compliance documentation for laboratory and pharmaceutical customers.
Instructor-led courses, webinars and workshops covering clinical microbiology techniques, accreditation standards and laboratory workflow optimization.
Technical support, maintenance contracts and a digital customer portal for ordering, tracking, accessing documentation and managing service requests for laboratory products and consumables.
Expertise Areas
- Clinical diagnostics and laboratory automation
- Molecular and syndromic diagnostics
- Microbial identification and mass spectrometry
- Pathogen genomics and antimicrobial-resistance analysis
Key Technologies
- Real-time PCR
- Multiplex PCR panels
- Next-generation sequencing (NGS)
- Mass spectrometry for microbial profiling
News & Updates
bioMérieux announces an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company using genome sequencing and machine learning to combat antibiotic-resistant infections.
bioMérieux launches VETFIRE™, a PCR kit for faster testing of equine infectious respiratory diseases.
A blog post discussing how antimicrobial stewardship programs impact patient care and combat antimicrobial resistance in ICUs.
BIOLOOP™ project to recycle plastic Petri dishes into new reagents packaging, reducing CO₂ emissions.
bioMérieux announces an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company using genome sequencing and machine learning to combat antibiotic-resistant infections.
bioMérieux launches VETFIRE™, a PCR kit for faster testing of equine infectious respiratory diseases.
A blog post discussing how antimicrobial stewardship programs impact patient care and combat antimicrobial resistance in ICUs.
BIOLOOP™ project to recycle plastic Petri dishes into new reagents packaging, reducing CO₂ emissions.